Vemurafenib enhances MHC induction inBRAFV600Ehomozygous melanoma cells
Author:
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.4161/onci.22890
Reference46 articles.
1. Melanoma survival in the United States, 1992 to 2005
2. Distinct Sets of Genetic Alterations in Melanoma
3. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
4. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Cited by 120 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Loss of function of ENT3 drives histiocytosis and inflammation through TLR-MAPK signaling;Blood;2023-11-16
2. PAK1 and Therapy Resistance in Melanoma;Cells;2023-09-28
3. Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion;Journal of Experimental & Clinical Cancer Research;2023-07-19
4. A Reconstructed Human Melanoma-in-Skin Model to Study Immune Modulatory and Angiogenic Mechanisms Facilitating Initial Melanoma Growth and Invasion;Cancers;2023-05-20
5. Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?;Cancer and Metastasis Reviews;2023-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3